|
| InsiderPie Expert Score
| P/E ratio
| Net margin
| ROA
| Net income per employee
|
| Aquestive Therapeutics, Inc.
|
N/A
| -4.9
| -147.4%
| -69.4%
| -€394.63K
|
| Deciphera Pharmaceuticals, Inc.
|
trending_flat
50
/ 100
| -12
| -108.9%
| -45.2%
| -€462.12K
|
| PolyPeptide Group AG
|
trending_flat
50
/ 100
| -16
| -7.3%
| -6.3%
| -€32.07K
|
| Dermapharm Holding SE
|
trending_flat
51
/ 100
| 17
| 9.1%
| 5.0%
| €29.70K
|
| Neurocrine Biosciences, Inc.
|
trending_flat
55
/ 100
| 35
| 13.9%
| 9.0%
| €166.71K
|
| Supernus Pharmaceuticals, Inc.
|
trending_flat
48
/ 100
| 27
| 9.7%
| 4.7%
| €82.44K
|
| Ironwood Pharmaceuticals, Inc.
|
trending_flat
50
/ 100
| -17
| -2.3%
| -2.0%
| -€23.67K
|
| Lifecore Biomedical, Inc.
|
trending_flat
48
/ 100
| -7.8
| -30.0%
| -16.2%
| -€63.66K
|
| AB Science S.A.
|
trending_flat
50
/ 100
| -4.2
| -970.4%
| -85.5%
| -€495.40K
|
| Zoetis Inc.
|
trending_flat
61
/ 100
| 26
| 27.8%
| 18.0%
| €163.07K
|
| Shield Therapeutics plc
|
trending_flat
50
/ 100
| -0.71
| -134.9%
| -104.7%
| -€878.65K
|
| Swedencare AB (publ)
|
trending_flat
50
/ 100
| 100
| 2.5%
| 0.7%
| €10.10K
|
| Boiron SA
|
trending_flat
50
/ 100
| 8.9
| 4.8%
| 8.2%
| €19.10K
|
| Aytu BioPharma, Inc.
|
trending_flat
50
/ 100
| -0.95
| -20.4%
| -10.9%
| -€114.55K
|
| Apontis Pharma AG
|
trending_flat
56
/ 100
| -8.5
| -12.3%
| -23.8%
| -€77.00K
|
| Eagle Pharmaceuticals, Inc.
|
trending_flat
50
/ 100
| 2.4
| 6.0%
| 3.8%
| €100.08K
|
| Acorda Therapeutics, Inc.
|
trending_flat
50
/ 100
| -0.0031
| -227.8%
| -322.9%
| -€2.23M
|
| Shionogi & Co., Ltd.
|
trending_flat
50
/ 100
| 13
| 38.9%
| 11.1%
| €194.94K
|
| Dr. Reddy's Laboratories Limited
|
trending_flat
48
/ 100
| 19
| 17.0%
| 10.9%
| €20.57K
|
| ECO Animal Health Group plc
|
trending_flat
52
/ 100
| 15
| 1.6%
| 2.3%
| €13.88K
|
| Intra-Cellular Therapies, Inc.
|
trending_flat
44
/ 100
| -186
| -11.0%
| -5.5%
| -€74.81K
|
| Allergy Therapeutics plc
|
trending_flat
50
/ 100
| -4
| -78.8%
| -117.7%
| -€161.68K
|
| Amneal Pharmaceuticals, Inc.
|
trending_flat
45
/ 100
| 1.1K
| 0.1%
| 0.1%
| €350.33
|
| Evolus, Inc.
|
trending_flat
50
/ 100
| -9.4
| -22.3%
| -27.1%
| -€143.58K
|
| SCYNEXIS, Inc.
|
trending_flat
50
/ 100
| -1.4
| -599.0%
| -32.2%
| -€600.53K
|
| PLx Pharma Inc.
|
trending_flat
50
/ 100
| -0.17
| -333.3%
| -45.6%
| -€815.49K
|
| Fagron NV
|
trending_flat
50
/ 100
| 11
| 9.2%
| 13.9%
| €39.47K
|
| Almirall, S.A.
|
trending_flat
55
/ 100
| 107
| 2.0%
| 0.9%
| €10.53K
|
| Recro Pharma, Inc.
|
trending_flat
50
/ 100
| -13
| -14.0%
| -8.6%
| -€44.33K
|
| HUTCHMED (China) Limited
|
trending_flat
53
/ 100
| 69
| 6.0%
| 3.0%
| €17.95K
|
| Elanco Animal Health Incorporated
|
trending_flat
51
/ 100
| 16
| 9.7%
| 3.2%
| €41.55K
|
| Evotec SE
|
trending_flat
54
/ 100
| -8.1
| -20.0%
| -8.6%
| -€32.63K
|
| Siegfried Holding AG
|
trending_flat
50
/ 100
| 137
| 11.0%
| 14.4%
| €78.91K
|
| Mithra Pharmaceuticals SA
|
trending_flat
50
/ 100
| -0.062
| -217.6%
| -81.4%
| -€863.41K
|
| Collegium Pharmaceutical, Inc.
|
trending_flat
50
/ 100
| 26
| 5.1%
| 2.3%
| €87.53K
|
| Sumitomo Pharma Co., Ltd.
|
trending_flat
51
/ 100
| 15
| 5.9%
| 3.2%
| €26.90K
|
| MERCK Kommanditgesellschaft auf Aktien
|
trending_flat
54
/ 100
| 17
| 13.5%
| 6.0%
| €48.51K
|
| Lantheus Holdings, Inc.
|
trending_flat
52
/ 100
| 21
| 17.8%
| 12.8%
| €288.96K
|
| Ipsen S.A.
|
trending_flat
51
/ 100
| 8.6
| 14.8%
| 15.4%
| €184.83K
|
| Dynavax Technologies Corporation
|
trending_flat
53
/ 100
| -22
| -16.7%
| -5.7%
| -€112.18K
|
| Vetoquinol SA
|
trending_flat
51
/ 100
| 7.6
| 10.7%
| 15.4%
| €45.35K
|
| ANI Pharmaceuticals, Inc.
|
trending_flat
44
/ 100
| -127
| -1.5%
| -0.8%
| -€10.60K
|
| Viatris Inc.
|
trending_flat
50
/ 100
| -2.8
| -26.5%
| -9.9%
| -€102.04K
|
| Takeda Pharmaceutical Company Limited
|
trending_flat
53
/ 100
| 52
| 3.1%
| 1.0%
| €15.75K
|
| Tilray Brands, Inc.
|
trending_flat
45
/ 100
| -0.43
| -114.4%
| -27.8%
| -€307.43K
|
| DURECT Corporation
|
trending_flat
51
/ 100
| -5.5
| 290.1%
| -27.9%
| -€142.69K
|
| CV Sciences, Inc.
|
trending_flat
50
/ 100
| -4.7
| -10.4%
| -19.5%
| -€28.45K
|
| Hikma Pharmaceuticals PLC
|
trending_flat
52
/ 100
| 9.2
| 10.5%
| 11.8%
| €59.49K
|
| Aerie Pharmaceuticals, Inc.
|
trending_flat
50
/ 100
| 0
| -17.1%
| -9.7%
| -€83.76K
|
| Trees Corporation
|
trending_flat
50
/ 100
| -0.36
| -41.7%
| -28.6%
| -€57.28K
|
| PetIQ, Inc.
|
trending_flat
50
/ 100
| 69
| 1.2%
| 1.5%
| €10.14K
|
| Sonoma Pharmaceuticals, Inc.
|
trending_flat
47
/ 100
| -1.3
| -23.8%
| -24.4%
| -€306.28K
|
| Eisai Co., Ltd.
|
trending_flat
52
/ 100
| 40
| 5.9%
| 3.3%
| €23.78K
|
| Alliance Pharma plc
|
trending_flat
50
/ 100
| -7.9
| -12.2%
| -11.9%
| -€174.30K
|
| Organogenesis Holdings Inc.
|
trending_flat
50
/ 100
| -42
| -2.6%
| -2.4%
| -€10.88K
|
| Esperion Therapeutics, Inc.
|
trending_flat
50
/ 100
| -2
| -35.8%
| -27.1%
| -€272.32K
|
| Sandoz Group AG
|
trending_flat
48
/ 100
| 75
| 1.9%
| 1.4%
| €12.13K
|
| Teva Pharmaceutical Industries Limited
|
trending_flat
63
/ 100
| -120
| -1.0%
| -0.4%
| -€3.68K
|
| Emergent BioSolutions Inc.
|
trending_flat
49
/ 100
| 2.4
| 16.5%
| 9.8%
| €133.54K
|
| China Shineway Pharmaceutical Group Limited
|
trending_flat
50
/ 100
| 0.15
| 20.0%
| 17.7%
| €63.61K
|
| Amphastar Pharmaceuticals, Inc.
|
trending_flat
51
/ 100
| 8
| 18.7%
| 8.3%
| €57.23K
|
| Cosmos Health Inc.
|
trending_flat
50
/ 100
| -0.8
| -27.9%
| -24.9%
| -€88.88K
|
| Biostar Pharmaceuticals, Inc.
|
trending_flat
50
/ 100
| 0.00028
| 294.2%
| 2.3%
| €4.03K
|
| Guardion Health Sciences, Inc.
|
trending_flat
50
/ 100
| 0.68
| 68.2%
| 41.7%
| €610.26K
|
| Swedish Orphan Biovitrum AB (publ)
|
trending_flat
51
/ 100
| 22
| 16.2%
| 6.4%
| €210.99K
|
